MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.

In a landmark week for medical innovation, the FDA approved or cleared multiple breakthrough technologies, from the first gene therapy for genetic hearing loss to a wireless brain implant trial for ...

Healthcare is the worst-performing ASX 200 sector, as one expert outlines the key headwinds weighing on the industry and ...

In Tulsa, Oklahoma, 12‑year‑old Ryder Boen is moved to tears as he experiences sound with a cochlear implant for the first ...

First-year biomedical engineering student Kaitlin Bertrand, who was born with Fraser Syndrome, has been awarded the 2026 ...